Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 287Breast Neoplasms 280Lung Neoplasms 134Prostatic Neoplasms 125Colorectal Neoplasms 113Carcinoma, Non-Small-Cell Lung 109Pancreatic Neoplasms 73Carcinoma, Hepatocellular 56Stomach Neoplasms 54Hematologic Neoplasms 53Brain Neoplasms 53Ovarian Neoplasms 52Urinary Bladder Neoplasms 49Multiple Myeloma 49Leukemia, Myeloid, Acute 48Esophageal Neoplasms 47Melanoma 46Disease 43Head and Neck Neoplasms 40Colonic Neoplasms 40Rectal Neoplasms 37Liver Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Neoplasm Metastasis 36Lymphoma 33Uterine Cervical Neoplasms 32Endometrial Neoplasms 32Leukemia, Lymphocytic, Chronic, B-Cell 31Thyroid Neoplasms 29Recurrence 29

Interventions

Sentinel Lymph Node Biopsy 1Ovariectomy 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × 90 days × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡